International Health Regulations

Debate between Andrew Stephenson and Kirsty Blackman

Tuesday 14th May 2024 Commons Chamber

[Andrew Stephenson]

At the moment we do not envisage any proposal that would require changes to domestic law, and it is highly unlikely that any proposals will come forward in that shape or form. I have some sympathy with what my right hon. Friend says: most organisations such as the WHO will always look to expand their remit, and look to gain more power in order to co-ordinate things. But these negotiations are being led by member states and sovereignty is a key part of the negotiating position of the vast majority of the countries involved. It is not just the UK arguing for this; countries around the world are arguing that this needs to be a high-level agreement that helps co-ordination and information-sharing but in no way ties countries’ hands in how we respond domestically to any future pandemic.

[Kirsty Blackman (Aberdeen North) (SNP)]

We cannot have a repeat of what the WHO called the catastrophic failure of the international community to ensure that covid-19 was fought everywhere with all of our abilities. It will require give and take, with give on the part of OECD countries commensurate with our comparative economic strength and population health. Although there may be disagreements across the House, I think we all agree that pandemics should be fought on an international basis and that other countries should be assisted, where we have the strength and ability to do that. Despite that level of agreement, there has been a persistent barrage of misinformation and disinformation, not least hitting our own inboxes. As negotiations on this proceed, what steps will the UK Government be taking to ensure that the public understand what the treaty will do and to tackle and robustly rebut the misinformation and disinformation that is being spread, particularly about this treaty?

[Andrew Stephenson]

The Scottish National party spokeswoman makes a very important point. There has been a lot of misinformation and disinformation, but that is in part the result of the transparency on all the amendments being published on the WHO website, for example, as well as various other information, which has allowed people to think that that is suddenly the kind of text that would be agreed. We need to be clear that no text whatsoever has been agreed; the negotiations continue. I think most people in this House, and hopefully outside, would recognise that the working draft text most recently published on the WHO website is a significant improvement on the initial drafts. I think we all share an ambition that we will get to a text that can be agreed, but it has to put national interests and national sovereignty at its heart. I will therefore do my best to ensure that the House is kept updated as further iterations of the text emerge—the latest version was published on the WHO website on 17 April.

Preventable Sight Loss

Debate between Andrew Stephenson and Kirsty Blackman

Tuesday 30th April 2024 Westminster Hall

[The Minister for Health and Secondary Care (Andrew Stephenson)]

It is always a pleasure to see a fellow Lancastrian in the Chair, Sir Mark. I thank the hon. Member for Wirral West (Margaret Greenwood) for bringing forward the debate. This is the second debate today on eye health to which I am responding on behalf of the Under-Secretary of State for Health and Social Care, my right hon. Friend the Member for South Northamptonshire (Dame Andrea Leadsom), who has been busy in the Tobacco and Vapes Bill Committee. I also thank those who contributed to the debate—the right hon. Member for Hayes and Harlington (John McDonnell), the hon. Member for Aberdeen North (Kirsty Blackman) and the shadow Minister, the hon. Member for Birmingham, Edgbaston (Preet Kaur Gill)—for their thoughtful contributions.

Preventing sight loss remains one of my right hon. Friend’s top priorities, and it is right that we should dedicate parliamentary time to this important issue. Losing one’s eyesight can be devastating, and I want to pay tribute to some of the charities that I did not have time to mention in this morning’s debate—Fight for Sight, the Vision Foundation and Sightsavers, to name just a few more.

About 2 million people live with sight loss in our country. That number is projected to double by 2050, mainly because of our ageing population. We are doing a huge amount to reduce the number, through preventive measures and early detection. One of the best ways to protect eyesight is through regular sight tests. That point was made eloquently by the hon. Member for Aberdeen North, and I am pleased to confirm to her that I am having my next eye test tomorrow morning.

This debate is why the NHS invests more than £500 million every year on free eye tests for people on benefits, people over 60, and people at risk of serious conditions. That investment delivered more than 12 million NHS sight tests to those groups between 2022 and 2023, and extensive discounts on glasses and contact lenses for children and people on income-related benefits, through NHS optical vouchers.

We have also taken great strides in preventing some of the causes of sight loss, including smoking and obesity. As I mentioned at the start, my right hon. Friend the Member for South Northamptonshire is taking our landmark Tobacco and Vapes Bill through the House, and we are backing quit-smoking campaigns with unprecedented funding and support.

On obesity, we have taken a raft of measures on sugar reduction and healthy eating. We have made strong progress in reducing the average sugar content in soft drinks through the soft drinks levy, and almost halved their sugar content between 2015 and 2019. For two years, we have also been restricting the placement of less-healthy products in shops and online, thereby helping consumers to make healthier choices.

Our wider prevention work goes hand in hand with our efforts to catch eye problems early. Glaucoma—which was covered in the debate this morning—and diabetic retinopathy are two of the main causes of preventable sight losses, and both can cause blindness if left untreated. That is why we are offering screening tests to nearly 4 million patients with diabetes at least once every two years. Since 2010, the number of adults between 16 and 64 who became visually impaired from diabetic retinopathy fell by almost a fifth. Our approach has been commended by the World Health Organisation, and we will build on that progress. In October, we begin phasing in optical coherence tomography scans as part of the screening programme, to reduce unnecessary referrals to hospital eye services and improve the quality of the service overall.

It is vital for patients who need to be in secondary care to have access to timely diagnosis and treatment. That is why we have set ambitious targets to recover services that suffered over the pandemic, through our elective recovery plan, which is backed by more than £8 billion of funding, and why we have expanded surgical hubs and harnessed capacity in the independent sector so that more patients can be seen more quickly. Our plan is working and it is delivering results. Waiting times are falling. The number of patients waiting 78 weeks or longer for ophthalmology treatment has reduced by 96% since its peak. But we know we have much further to go.

While we work to recover from the pandemic, we are reforming eye care services to be fit for the future. NHS England’s transformation programme is currently funding seven projects across each ICS area, testing how improved IT links between primary and secondary care could allow patients to be assessed and triaged virtually. Where appropriate, that would keep patients out of hospital, freeing up hospital eye-service capacity for those who need specialist care the most.

The initiatives have shown promising results. For example, the project in North Central London ICS has improved the flow of information from community optometry to Moorfields Eye Hospital, reducing the triage time from 11 days down to one. The appropriate use of clinics has doubled to more than 70% and reduced the waiting time for first appointments by up to 35 days. NHS England is now using the data from the projects to build the case for a wider roll-out.

[Kirsty Blackman]

I appreciate what the Minister is doing in this policy area. Some of the initiatives he just mentioned, such as electronic assessments and triaging electronically, were put in place in Scotland seven years ago. We decided that they were working and that we would roll them out. Has he spoken to Scottish colleagues and looked at the work done in Scotland in order to ensure that the Government do not have to replicate the same pilots that we have proven do work, so that people can get treatment and things can be put in place more quickly?

Oral Answers to Questions

Debate between Andrew Stephenson and Kirsty Blackman

Tuesday 23rd April 2024 Commons Chamber

[Kirsty Blackman (Aberdeen North) (SNP)]

A recent Nuffield Trust report shows that medicine shortages are a new normal in the UK. The Minister might claim that this is a global issue, but as the report highlights, shortages are being made worse by Brexit. For example, the creation of a requirement for customs checks at the border and leaving the European Medicines Agency have disrupted the previously smooth supply of medicines. What urgent action will the Minister take to help to tackle the disastrous effects of Brexit on UK medicine supplies?

[Andrew Stephenson]

The SNP, as usual, is a broken record. We all know that diabetes medicine shortages are a global issue affecting countries not just across the whole of the European Union, but across the whole world. Medicine supply chains are highly regulated, complex and global. Issues can occur for multiple reasons, including manufacturing difficulties, regulatory non-compliance, surges in demand, availability of raw materials, sudden spikes in demand, and issues related to the distribution of the product. But once again, as always, the grievance culture of the SNP is: blame everything on Brexit.